Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804609 · ClinicalTrials.gov registry record · NA
Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00804609: Completed NA study, sponsored by Stanford University.
NCT00804609 is a NA study that has completed, run by Stanford University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804609, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To evaluate the levels of morphine in a patient's blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine also given in the epidural space.
Interventions
- DRUG DepoDur following epidural lidocaine
- DRUG DepoDur following spinal anesthetic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00804609
The ClinicalTrials.gov registry entry for NCT00804609 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DepoDur following epidural lidocaine is the first listed.
NCT00804609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00804609 about?
NCT00804609 is a clinical study titled "Effects of Epidural Lidocaine on the Pharmacokinetic and Pharmacodynamic Profiles of DepoDur® After Cesarean Delivery". To evaluate the levels of morphine in a patient's blood when morphine is given into the epidural space in the form of DepoDur® either alone or following a dose of lidocaine also given in the epidural space.
What is the current status of trial NCT00804609?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00804609?
The interventions under investigation include: DepoDur following epidural lidocaine (DRUG), DepoDur following spinal anesthetic (DRUG).
Who is sponsoring clinical trial NCT00804609?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.